179 related articles for article (PubMed ID: 11336404)
1. Carrier screening for Gaucher disease in couples of mixed ethnicity.
Wallerstein R; Starkman A; Jansen V
Genet Test; 2001; 5(1):61-4. PubMed ID: 11336404
[TBL] [Abstract][Full Text] [Related]
2. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
3. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
[TBL] [Abstract][Full Text] [Related]
4. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
5. Tay-Sachs disease screening and counseling families at risk for metabolic disease.
Sutton VR
Obstet Gynecol Clin North Am; 2002 Jun; 29(2):287-96. PubMed ID: 12108829
[TBL] [Abstract][Full Text] [Related]
6. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
[TBL] [Abstract][Full Text] [Related]
8. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
[TBL] [Abstract][Full Text] [Related]
9. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population.
Kannai R; Chertok IR
Isr Med Assoc J; 2006 May; 8(5):347-50. PubMed ID: 16805236
[TBL] [Abstract][Full Text] [Related]
10. Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations.
Zeevi DA; Altarescu G; Weinberg-Shukron A; Zahdeh F; Dinur T; Chicco G; Herskovitz Y; Renbaum P; Elstein D; Levy-Lahad E; Rolfs A; Zimran A
J Clin Invest; 2015 Oct; 125(10):3757-65. PubMed ID: 26426075
[TBL] [Abstract][Full Text] [Related]
11. Gaucher disease: gene frequencies and genotype/phenotype correlations.
Grabowski GA
Genet Test; 1997; 1(1):5-12. PubMed ID: 10464619
[TBL] [Abstract][Full Text] [Related]
12. Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.
Balwani M; Fuerstman L; Kornreich R; Edelmann L; Desnick RJ
Arch Intern Med; 2010 Sep; 170(16):1463-9. PubMed ID: 20837833
[TBL] [Abstract][Full Text] [Related]
13. Prenatal healthcare providers' Gaucher disease carrier screening practices.
Falcone D; Wood EM; Mennuti M; Xie SX; Van Deerlin VM
Genet Med; 2012 Oct; 14(10):844-51. PubMed ID: 22653536
[TBL] [Abstract][Full Text] [Related]
14. An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H.
Bronstein S; Karpati M; Peleg L
Isr Med Assoc J; 2014 Nov; 16(11):683-5. PubMed ID: 25558695
[TBL] [Abstract][Full Text] [Related]
15. Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
Ferreira JC; Schreiber-Agus N; Carter SM; Klugman S; Gregg AR; Gross SJ
Am J Obstet Gynecol; 2014 Sep; 211(3):197-204. PubMed ID: 24508465
[TBL] [Abstract][Full Text] [Related]
16. Attitudes of couples identified through screening as carriers of Gaucher disease type 1.
Zuckerman S; Lahad A; Zimran A; Levy-Lahad E; Sagi M
Clin Genet; 2008 Dec; 74(6):566-70. PubMed ID: 18651845
[TBL] [Abstract][Full Text] [Related]
17. DNA-based carrier screening in the Ashkenazi Jewish population.
Zhang B; Dearing L; Amos J
Expert Rev Mol Diagn; 2004 May; 4(3):377-92. PubMed ID: 15137904
[TBL] [Abstract][Full Text] [Related]
18. Economic analysis of chromosome testing in couples with recurrent miscarriage to prevent handicapped offspring.
van Leeuwen M; Vansenne F; Korevaar JC; van der Veen F; Goddijn M; Mol BW
Hum Reprod; 2013 Jul; 28(7):1737-42. PubMed ID: 23613277
[TBL] [Abstract][Full Text] [Related]
19. The 1226G (N370S) Gaucher mutation among patients with Legg-Calve-Perthes disease.
Kenet G; Hayek S; Mor M; Lubetsky A; Miller L; Rosenberg N; Mosheiff R; Itzchaki M; Elstein D; Wientroub S; Zimran A
Blood Cells Mol Dis; 2003; 31(1):72-4. PubMed ID: 12850487
[TBL] [Abstract][Full Text] [Related]
20. Reliable co-segregation analysis for prenatal diagnosis and heterozygote detection in Gaucher disease.
Cormand B; Montfort M; Chabás A; Grinberg D; Vilageliu LL
Prenat Diagn; 1998 Mar; 18(3):207-12. PubMed ID: 9556036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
